<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091179</url>
  </required_header>
  <id_info>
    <org_study_id>39202</org_study_id>
    <nct_id>NCT03091179</nct_id>
  </id_info>
  <brief_title>Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Short Laryngologic Surgery</brief_title>
  <official_title>The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Short Laryngologic Surgical Procedures.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate whether selected, short laryngologic surgical
      procedures can be safely and potentially more effectively performed without the use of
      endotracheal tube or jet ventilation, under completely tubeless conditions. The patient's gas
      exchange will be supported by rapid insufflation of high-flow oxygen through specialized
      nasal cannulae: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange
      (THRIVE).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 17, 2017</start_date>
  <completion_date type="Anticipated">June 12, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 12, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of THRIVE on oxygenation</measure>
    <time_frame>intraoperative</time_frame>
    <description>oxygen saturation by pulse oximetry (SpO2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of THRIVE on operating time</measure>
    <time_frame>intraoperative</time_frame>
    <description>surgical duration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of THRIVE on patients' recovery</measure>
    <time_frame>1-2 hours after procedure</time_frame>
    <description>recovery room time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of THRIVE on patients' recovery</measure>
    <time_frame>from recovery room stay to 7th day after surgery</time_frame>
    <description>consumption of analgesic drugs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of THRIVE on patients' recovery</measure>
    <time_frame>after discharge to 7th day after surgery</time_frame>
    <description>voice improvement numerical scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Otorhinolaryngologic Surgical Procedures</condition>
  <arm_group>
    <arm_group_label>THRIVE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high flow nasal oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Endotracheal tube</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>tracheal intubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>THRIVE</intervention_name>
    <description>active nasal oxygen delivery system</description>
    <arm_group_label>THRIVE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endotracheal tube</intervention_name>
    <description>a plastic tube for mechanical ventilation</description>
    <arm_group_label>Endotracheal tube</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting for short, non-laser laryngologic surgery

        Exclusion Criteria:

          1. Patients with significantly decreased myocardial function (ejection fraction &lt; 50%)

          2. Patients with abnormal cardiac rhythm and conduction abnormalities, except for
             patients with isolated, asymptomatic premature atrial and ventricular contractions.

          3. Patients with significant peripheral vascular disease, such as those with the symptoms
             of intermittent claudication.

          4. Patients with known significant cerebrovascular disease, such as history of
             cerebrovascular accidents (CVAs) and transient ischemic attacks (TIAs).

          5. Patients with significant renal insufficiency, as manifested by estimated glomerular
             filtration rate (eGFR) &lt; 60 ml/min/1.73 m2.

          6. Patients with electrolyte (K+, Ca++) abnormalities, as determined by the lab values
             outside of a normal range.

          7. Patients with the history or symptoms of increased intracranial pressure or reduced
             intracranial compliance (e.g. headaches, nausea and vomiting, visual changes, mental
             changes).

          8. Patients with skull base defects.

          9. Patients with pulmonary hypertension who have pulmonary artery pressures above the
             normal range.

         10. Patients with significant chronic obstructive or restrictive lung diseases, as
             manifested by known history of baseline chronic hypoxia and/or hypercapnia, and/or
             baseline room air SpO2 &lt; 95%.

         11. Obese patients with BMI above 35 kg/m2.

        13. Patients with severe and poorly controlled gastroesophageal reflux disease despite
        medical treatment.

        14. Patients with hiatal hernia and full stomach patients. 15. Patient's refusal to
        participate in the study. 16. Patients who do not understand English or mentally
        handicapped. 17. Pregnant or breastfeeding patients.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael D Amylon, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vladimir Nekhendzy, MD</last_name>
    <phone>6504984055</phone>
    <email>nek@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford Hospital and Clinics</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Nekhendzy, MD</last_name>
      <phone>650-498-4055</phone>
      <email>nek@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 5, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>April 24, 2017</last_update_submitted>
  <last_update_submitted_qc>April 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Vladimir Nekhendzy</investigator_full_name>
    <investigator_title>Clinical Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>airway management</keyword>
  <keyword>high flow nasal oxygen</keyword>
  <keyword>high flow nasal cannula</keyword>
  <keyword>THRIVE</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

